![]() |
|
|
Vol. 291, Issue 2, 903-910, November 1999
Department of Pharmacology, Research and Development Center,
Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut
We report on the development of a method for repeated monitoring of
mucosal permeability that allows assessment of the severity of colitis
and evaluation of treatment efficacy in HLA-B27 transgenic rats. We
determined the extent to which intestinal permeability related to stool
condition, colon weight, and histological pathology in precolitic and
diseased rats up to 29 weeks old. Intestinal permeability was measured
by the urinary excretion of iodixanol at 24 h after oral
administration. Mean permeability values increased significantly with
age in HLA-B27 rats but remained decreased in the background strain
Fischer-344 (F-344) control animals. Macroscopic evaluation of HLA-B27
rat colons between 20 and 24 weeks old showed colonic thickening with
colonic wet weights increased from 3.4 ± 0.13 mg/kg b.wt. in
F-344 rats to 6.79 ± 0.73 mg/kg b.wt. (p < .05) in HLA-B27 rats. Histological examination of HLA-B27 rat colons
confirmed the colonic inflammation as a chronic active mononuclear cell
infiltrate. The increase in colon weight was associated with an
increase in permeability: 1.16 ± 0.17 mg iodixanol versus
5.37 ± 1.3 mg of iodixanol in F-344 and HLA-B27 rats,
respectively. Three weeks treatment of HLA-B27 rats with cyclosporin A,
but not sulfasalazine, showed a dose-dependent decrease in mucosal permeability and colon weight. Neither treatment improved stool condition. We conclude that the measurement of intestinal permeability by iodixanol excretion is a useful biochemical marker that is associated with increases in colonic weight and histological evaluation of inflammation. These data indicate that this technique may be valuable for diagnostic and evaluation purposes in preclinical models
of inflammatory bowel disease.
This article has been cited by other articles:
![]() |
J. Leblond, F. Le Pessot, A. Hubert-Buron, C. Duclos, J. Vuichoud, M. Faure, D. Breuille, P. Dechelotte, and M. Coeffier Chemotherapy-Induced Mucositis Is Associated with Changes in Proteolytic Pathways Experimental Biology and Medicine, February 1, 2008; 233(2): 219 - 228. [Abstract] [Full Text] [PDF] |
||||